InvestorsHub Logo
Followers 91
Posts 11298
Boards Moderated 0
Alias Born 06/06/2014

Re: None

Monday, 04/29/2024 10:47:37 AM

Monday, April 29, 2024 10:47:37 AM

Post# of 459168
Another small biotech just posted their phase 2/3 AD results. Annovis's trial is a useful comparison to ours. Note size, results, endpoints, disclosures. Also note timelines (eg LPLV mid-Feb). They have interesting things to say about their biomarkers.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News